Debt to Equity Ratio Chart

View Debt to Equity Ratio for LMED.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 0.0678
March 31, 2026 0.0593
December 31, 2025 -0.6259
September 30, 2025 -0.5833
June 30, 2025 -0.595
March 31, 2025 -0.5993
December 31, 2024 -0.5915
September 30, 2024 -0.6245
March 31, 2024 1.068
December 31, 2023 -0.6944
September 30, 2023 0.6734
June 30, 2023 0.0649
March 31, 2023 0.0625
December 31, 2022 -0.742
September 30, 2022 -0.6377
June 30, 2022 -0.5136
March 31, 2022 -0.5117
December 31, 2021 -0.5566
September 30, 2021 -0.488
June 30, 2021 -0.5326
March 31, 2021 -0.6593
December 31, 2020 -0.5049
September 30, 2020 -0.9338
June 30, 2020 -0.8579
Date Value
March 31, 2020 -0.9573
December 31, 2019 -1.019
September 30, 2019 -0.8245
June 30, 2019 -0.8182
March 31, 2019 -0.8274
June 30, 2018
March 31, 2018
March 31, 2016 0.8096
December 31, 2015 0.4752
September 30, 2015 0.3122
June 30, 2015 0.1455
March 31, 2015 0.1201
December 31, 2014 0.1051
September 30, 2014 0.0758
June 30, 2014 0.0433
March 31, 2014 0.0566
December 31, 2013 0.0508
September 30, 2013 0.0407
June 30, 2013 -0.6472
September 30, 2010 0.00
June 30, 2010 0.00
March 31, 2010 0.00
September 30, 2009 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
SCWorx Corp. 0.00
Health Catalyst, Inc. 1.686
GoodRx Holdings, Inc. 0.8322
Claritev Corp. -15.93
iSpecimen, Inc. 0.1387

Debt to Equity Ratio Related Metrics